New Zealand markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.5200-0.0100 (-0.65%)
At close: 04:00PM EST
1.5100 -0.01 (-0.66%)
After hours: 08:00PM EST
Full screen
Loading interactive chart…
  • Business Wire

    bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network

    CAMBRIDGE, England & BOSTON, February 28, 2024--bit.bio, the company coding human cells for novel cures, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced bit.bio as an inaugural partner of the Ginkgo Technology Network. The Network, launched today, is a groundbreaking ecosystem of cutting edge technology partners, committed to collaborating with Ginkgo to provide new, integrated capabilities to drive success in customer

  • PR Newswire

    Ginkgo Bioworks Provides Compensation Information Related to Recent Acquisitions

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced that in connection to its transaction with Patch Biosciences, Inc. ("Patch Bio") on February 26, 2024, Ginkgo approved grants of restricted stock units with an aggregate grant date fair value of $4,292,000 to eight Patch Bio employees, and in connection with its acquisition of Reverie Labs, Inc. ("Reverie") on February 23, 2024, Ginkgo approved grants of restricted stock uni

  • PR Newswire

    Ginkgo Bioworks Acquires Patch Biosciences, Expanding Suite of Genetic Medicine Capabilities Available to Customers

    Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of Patch Biosciences, which has built an AI platform for sequence design that enables more effective, specific, and durable genetic medicines and was backed by Andreessen Horowitz (a16z) Bio + Health, Casdin Capital, and S32. The acquisition is intended to strengthen Ginkgo's Gene Therapy Services, Cell Therapy Services, and RNA Therapeutics Services.